Tei index in adult patients submitted to adriamycin chemotherapy: Failure to predict early systolic dysfunction

International Journal of Cardiovascular Imaging

Volumn 23, Issue 2, 2007, Pages 185-191

  Rohde, Luis E ^a,b   Baldi, Alexandre ^a,b   Weber, Cristiane ^a,b   Geib, Guilherme ^a,b   Mazzotti, Nicolle Gollo ^a,b   Fiorentini, Marlon ^a,b   Roggia, Murilo ^a,b   Pereira, Rodrigo ^a,b   Clausell, Nadine ^a,b  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Adriamycin; Cardiac function; Echocardiography

Indexed keywords

BLEOMYCIN; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; FLUOROURACIL; PREDNISONE; VINBLASTINE; VINCRISTINE;

ADULT; ARTICLE; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CARDIOTOXICITY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DRUG MEGADOSE; ECHOCARDIOGRAPHY; FEMALE; HEART DISEASE; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; SENSITIVITY AND SPECIFICITY; SYSTOLIC DYSFUNCTION;

EID: 33947261623     PISSN: 15695794     EISSN: 18758312     Source Type: Journal    
DOI: 10.1007/s10554-006-9145-0     Document Type: Article

References (24)

1. Lipshultz SE, Colan SD, Gelber RD et al (1991) Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood. N Engl J Med 324:808-815
2. Mitani I, Jain D, Joska TM et al (2003) Doxorubicin cardiotoxicity: Prevention of congestive heart failure with serial cardiac function monitoring with equilibrium radionuclide angiocardiography in the current era. J Nucl Cardiol 10:132-139
3. Schwartz RG, McKenzie WB (1987) Cardiac heart failure and left ventricular dysfunction complicating doxorubicin therapy. Am J Med 82:1109-1118
4. Schmitt K, Tulzer G, Merl M et al (1995) Early detection of doxorubicin and daunorubicin cardiotoxicity by echocardiography: Diastolic versus systolic parameters. Eur J Pediatr 154:201-204
5. Galli MA, Conter V, Zanetto F, Jankovic M et al (1987) Cardiotoxicity in children treated with anthracyclines: The role of M-mode echocardiography. Haematologica 72:347-50
6. Hausdorf G, Morf G, Beron G, Erttmann R et al (1988) Long term doxorubicin cardiotoxicity in childhood: Non-invasive evaluation of the contractile state and diastolic filling. Br Heart J 60:309-15
7. Nousiainen T, Vanninen E, Jantunen E, et al (2001) Comparison of echocardiography and radionuclide ventriculography in the follow-up of left ventricular systolic function in adult lymphoma patients during doxorubicin therapy. J Intern Med 249:297-303
8. Bonow RO, Bacharach SL, Green MV et al (1981) Impaired left ventricular diastolic filling in patients with coronary artery disease: Assessment with radionuclide angiography. Circulation 64:315-323
9. Bonow RO, Rosing DR, Bacharach SL, et al (1981) Effects of verapamil on left ventricular systolic function and diastolic filling in patients with hypertrophic cardiomyopathy. Circulation 64:787-96
10. Soufer R, Wohlgelernter D, Vita NA, et al (1985) Intact systolic left ventricular function in clinical congestive heart failure. Am J Cardiol 55:1032-1036
11. Rabelo E, De Angelis K, Bock P, et al (2001) Baroreflex sensitivity and oxidative stress in adriamycin-induced heart failure. Hypertension 38:576-580
12. Tei C (1995) New non-invasive index for combined systolic and diastolic ventricular function. Am J Cardiol 26:135-136
13. Bruch C, Schmermund A, Marin D, et al (2000) Tei-index in patients with mild-to-moderate congestive heart failure. Eur Heart J 21:1888-1895
14. Harjai KJ, Scott L, Vivekananthan K et al (2002) The Tei index: A new prognostic index for patients with symptomatic heart failure. J Am Soc Echocardiogr 15:864-868
15. Ishii M, Tsutsumi T, Himeno W, et al (2000) Sequential evaluation of left ventricular myocardial performance in children after anthracycline therapy. Am J Cardiol 86:1279-1281, A9
16. Schiller NB (1991) Two-dimensional echocardiographic determination of ventricular volume, systolic function, and mass. Summary and discussion of the 1989 recommendations of the American Society of Echocardiography. Circulation 84:1280-1287
17. Johnson SA (2006). Anthracycline-induced cardiotoxicity in adult hematologic malignancies. Semin Oncol 33(Suppl 8):S22-S27
18. Keefe DL (2001) Anthracycline-induced cardiomyopathy. Semin Oncol 28:2-7
19. Cittadini A, Fazio S, D'Ascia C, et al (1991) Subclinical cardiotoxicity by doxorubicin: A pulsed Doppler echocardiographic study. Eur Heart J 12:1000-1005
20. Stoddard MF, Seeger J, Liddell NE, et al (1992) Prolongation of isovolumetric relaxation time as assessed by Doppler echocardiography predicts doxorubicin-induced systolic dysfunction in humans. J Am Coll Cardiol 20:62-69
21. Tei C, Ling LH, Hodge DO, et al (1995) New index of combined systolic and diastolic myocardial performance: A simple and reproducible measure of cardiac function - a study in normal and dilated cardiomyopathy. Am J Cardiol 26:357-366
22. Tei C, Dujardin KS, Hodge DO, et al (1996) Doppler index combining systolic and diastolic myocardial performance: Clinical value in cardiac amyloidosis. J Am Coll Cardiol 28:658-664
23. Ärnlöov J, Ingelsson E, Risérus U, Andrén B, Lind L (2004). Myocardial performance index, a Doppler-derived index of global left ventricular function, predicts congestive heart failure in elderly men. Eur Heart J 25:2220-2225
24. Belham M, Kruger A, Pritchard C (2006) The Tei index identifies a differential effect on left and right ventricular function with low-dose anthracycline chemotherapy. J Am Soc Echocardiogr 19(2):206-210